[ESPR] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
04-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- 12.96%
YoY- -16.21%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 15,401 14,409 40,659 7,978 9,638 3,833 212,236 -82.51%
PBT -65,119 -69,386 -43,668 -90,935 -104,476 -85,437 124,611 -
Tax 13,430 13,667 11,153 8,139 8,795 4,970 4,721 100.38%
NP -65,119 -69,386 -43,668 -90,935 -104,476 -85,437 124,611 -
Tax Rate - - - - - - -3.79% -
Total Cost 80,520 83,795 84,327 98,913 114,114 89,270 87,625 -5.46%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin -422.82 -481.55 -107.40 -1,139.82 -1,084.00 -2,228.99 58.71 -
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS -1.77 -2.62 -1.67 -3.50 -3.89 -3.07 4.50 -
EPS Diluted -1.77 -2.62 -1.67 -3.50 -3.89 -3.07 4.32 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.